These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34912334)

  • 1. Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.
    Olguín-Contreras LF; Mendler AN; Popowicz G; Hu B; Noessner E
    Front Immunol; 2021; 12():750478. PubMed ID: 34912334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
    Jaiswal AI; Dubey C; Swain SL; Croft M
    Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies.
    Dobrin A; Lindenbergh PL; Shi Y; Perica K; Xie H; Jain N; Chow A; Wolchok JD; Merghoub T; Sadelain M; Hamieh M
    Nat Cancer; 2024 May; 5(5):760-773. PubMed ID: 38503896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
    Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
    Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.
    Altvater B; Pscherer S; Landmeier S; Niggemeier V; Juergens H; Vormoor J; Rossig C
    Clin Exp Immunol; 2006 Jun; 144(3):447-57. PubMed ID: 16734614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.
    Alabanza L; Pegues M; Geldres C; Shi V; Wiltzius JJW; Sievers SA; Yang S; Kochenderfer JN
    Mol Ther; 2017 Nov; 25(11):2452-2465. PubMed ID: 28807568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells.
    Zolov SN; Rietberg SP; Bonifant CL
    Cytotherapy; 2018 Oct; 20(10):1259-1266. PubMed ID: 30309710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Blood; 2002 Nov; 100(9):3155-63. PubMed ID: 12384413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming of a novel subset of CD28+ rapidly expanding high-avidity effector memory CTL by post maturation electroporation-CD40L dendritic cells is IL-12 dependent.
    DeBenedette MA; Calderhead DM; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
    J Immunol; 2008 Oct; 181(8):5296-305. PubMed ID: 18832685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
    Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
    Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function.
    Hoogi S; Eisenberg V; Mayer S; Shamul A; Barliya T; Cohen CJ
    J Immunother Cancer; 2019 Sep; 7(1):243. PubMed ID: 31500665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.
    Kuhn NF; Purdon TJ; van Leeuwen DG; Lopez AV; Curran KJ; Daniyan AF; Brentjens RJ
    Cancer Cell; 2019 Mar; 35(3):473-488.e6. PubMed ID: 30889381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor.
    Fisher J; Abramowski P; Wisidagamage Don ND; Flutter B; Capsomidis A; Cheung GW; Gustafsson K; Anderson J
    Mol Ther; 2017 May; 25(5):1234-1247. PubMed ID: 28341563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1-CD28-enhanced receptor and CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumors.
    Chen X; Zhao X; Mou X; Zhao J; Zhang Z; Zhang X; Huang J; Liu Y; Wang F; Zhang M; Wang L; Gu W; Zhang Y
    Biomed Pharmacother; 2024 Jun; 175():116800. PubMed ID: 38788547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
    Johnson-Léger C; Christensen J; Klaus GG
    Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD40 ligand in costimulation and T-cell activation.
    Grewal IS; Flavell RA
    Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.
    Roselli E; Boucher JC; Li G; Kotani H; Spitler K; Reid K; Cervantes EV; Bulliard Y; Tu N; Lee SB; Yu B; Locke FL; Davila ML
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34706886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
    Benda B; Ljunggren HG; Peach R; Sandberg JO; Korsgren O
    Cell Transplant; 2002; 11(7):715-20. PubMed ID: 12518898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
    Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
    Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.